Lv4
580 积分 2025-04-03 加入
A Critical Review of Properties and Analytical/Bioanalytical Methods for Characterization of Cetuximab
2天前
已完结
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients
2天前
已完结
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines
2天前
已完结
15P Topical strategy to prevent skin toxicities from bispecific-EGFR inhibitors by blocking drug-receptor interactions in skin
3天前
已完结
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study
4天前
已完结
Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study
8天前
已完结
Dual-payload ADCs move into first oncology clinical trials
18天前
已完结
Abstract 2621: Preclinical Efficacy of DM002, a bispecific HER3 × MUC1 antibody-drug conjugate with a novel DNA topoisomerase I inhibitor, in solid tumor models
21天前
已关闭
Abstract 2621: Preclinical Efficacy of DM002, a bispecific HER3 × MUC1 antibody-drug conjugate with a novel DNA topoisomerase I inhibitor, in solid tumor models
21天前
已关闭
Preclinical evaluation of DB-1419, a novel bifunctional and bispecific anti-B7-H3×PD-L1 antibody-drug conjugate
1个月前
已完结
皖公网安备34019202002308
